Bioavailability of Chemopreventive and Nutritional Compounds in Broccoli
Bioavailability of Bioactive Compounds in Broccoli
1 other identifier
interventional
7
1 country
1
Brief Summary
The aim of this study was to determine the absorption of isothiocyanates (ITC) after ingestion of kailan-hybrid broccoli through the analysis of the correspondent urinary biomarkers. Furthermore, the effect of cooking (microwave) on the mentioned metabolic fate of these ITC was studied comparing to the uncooked vegetable.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for early_phase_1
Started Jul 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedFirst Submitted
Initial submission to the registry
November 30, 2012
CompletedFirst Posted
Study publicly available on registry
December 6, 2012
CompletedDecember 6, 2012
December 1, 2012
Same day
November 30, 2012
December 4, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Metabolic fate of ITC of the kailan-hybrid broccoli after human comsuption
Glucosinolates (sulphur-containing compounds) are hydrolyzed by the plant enzyme myrosinase to isothiocyanates (ITC), which have chemopreventive properties. Previous studies have shown that cooking process of vegetables may vary the human absorption of the correspondent nutritional and bioactive compounds.
Up to 4 weeks
Study Arms (2)
Raw
EXPERIMENTALBroccoli,200 grams
cooked
EXPERIMENTALMicrowaved, 200 grams
Interventions
Eligibility Criteria
You may qualify if:
- Subjects with a body mass index between 19 and 28.
- Subjects age: 22-50 years-old.
- Good health of subjects: confirmed by medical history, physical examination and clinical laboratory analysis of urine and blood (complete blood count and liver function markers including serum glutamic-pyruvic transaminase bilirubin test and glucose-6-phosphate dehydrogenase).
You may not qualify if:
- Tobacco smoking.
- Use of regular medications.
- Had taken antibiotics for 4 weeks immediately preceding the study.
- History of kidney stones, diabetes mellitus, bleeding disorders or family history of iron overload/hemochromatosis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital General Universitario Reina Sofía
Murcia, Murcia, 30003, Spain
Study Officials
- STUDY CHAIR
Maria Concepcion Maeztu Sardiña, Doctor
Comité ético de investigación clínica
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
November 30, 2012
First Posted
December 6, 2012
Study Start
July 1, 2011
Primary Completion
July 1, 2011
Study Completion
July 1, 2011
Last Updated
December 6, 2012
Record last verified: 2012-12